The FDA granted an orphan drug designation for the novel drug, NT-17, to treat people with acute radiation syndrome. The Food and Drug Administration (FDA) has granted Orphan Drug Designation for the ...
CLAREMONT, Calif.--(BUSINESS WIRE)--Synedgen, Inc., a biotechnology company targeting human glycobiology to treat gastrointestinal diseases, today announced a partnership valued at up to $119 million ...
The writers of Star Trek once imagined that in the 22nd century, a drug named "hyronalin" would be invented to treat and prevent radiation's biological effects, something that in the real world we ...
FREMONT, CA / ACCESS Newswire / January 28, 2026 / Tivic Health ® Systems, Inc. (Nasdaq:TIVC), a late-stage immunotherapeutics company, today announced that it delivered an invited presentation at a ...
Impact of Simultaneous Circulating Tumor DNA and Tissue Genotyping in the Workup of Stage IV Lung Adenocarcinoma on Quality of Care in an Academic Community Medical Center AYAs who received RT and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results